Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease

Joel Papak, Devan Kansagara

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hyperglycemia in patients with and without known diabetes is a common finding in patients hospitalized with cardiovascular disease, and is associated with poor outcomes. Investigators have been examining the role of insulin to treat patients with acute myocardial infarction since the 1960's. Until the 1990's most studies evaluated fixed doses of glucose-insulin-potassium (GIK) infusions. The Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) trial, published in 1995, evaluated the role of adjustable-dose insulin infusion to lower blood glucose. Its promising results spurred further interest and a number of trials evaluating the use of insulin to lower blood glucose in hospitalized patients - many of which included patients with cardiovascular disease - have been conducted over the last two decades with conflicting results. This manuscript reviews the epidemiology and pathophysiology of hyperglycemia in hospitalized patients, summarizes the evidence for benefits and harms of using insulin to treat hyperglycemic patients hospitalized with cardiovascular disease, and offers some practical management considerations.

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
Volume110
Issue numberSUPPL. 9
DOIs
StatePublished - Nov 6 2012

Fingerprint

Hyperglycemia
Diabetes Mellitus
Cardiovascular Diseases
Insulin
Blood Glucose
Myocardial Infarction
Glucose
Potassium
Epidemiology
Research Personnel

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease. / Papak, Joel; Kansagara, Devan.

In: American Journal of Cardiology, Vol. 110, No. SUPPL. 9, 06.11.2012.

Research output: Contribution to journalArticle

@article{4eee08ed2746490f9b318d56d2a8caf8,
title = "Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease",
abstract = "Hyperglycemia in patients with and without known diabetes is a common finding in patients hospitalized with cardiovascular disease, and is associated with poor outcomes. Investigators have been examining the role of insulin to treat patients with acute myocardial infarction since the 1960's. Until the 1990's most studies evaluated fixed doses of glucose-insulin-potassium (GIK) infusions. The Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) trial, published in 1995, evaluated the role of adjustable-dose insulin infusion to lower blood glucose. Its promising results spurred further interest and a number of trials evaluating the use of insulin to lower blood glucose in hospitalized patients - many of which included patients with cardiovascular disease - have been conducted over the last two decades with conflicting results. This manuscript reviews the epidemiology and pathophysiology of hyperglycemia in hospitalized patients, summarizes the evidence for benefits and harms of using insulin to treat hyperglycemic patients hospitalized with cardiovascular disease, and offers some practical management considerations.",
author = "Joel Papak and Devan Kansagara",
year = "2012",
month = "11",
day = "6",
doi = "10.1016/j.amjcard.2012.08.034",
language = "English (US)",
volume = "110",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "SUPPL. 9",

}

TY - JOUR

T1 - Management of hyperglycemia in a hospitalized patient with diabetes mellitus and cardiovascular disease

AU - Papak, Joel

AU - Kansagara, Devan

PY - 2012/11/6

Y1 - 2012/11/6

N2 - Hyperglycemia in patients with and without known diabetes is a common finding in patients hospitalized with cardiovascular disease, and is associated with poor outcomes. Investigators have been examining the role of insulin to treat patients with acute myocardial infarction since the 1960's. Until the 1990's most studies evaluated fixed doses of glucose-insulin-potassium (GIK) infusions. The Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) trial, published in 1995, evaluated the role of adjustable-dose insulin infusion to lower blood glucose. Its promising results spurred further interest and a number of trials evaluating the use of insulin to lower blood glucose in hospitalized patients - many of which included patients with cardiovascular disease - have been conducted over the last two decades with conflicting results. This manuscript reviews the epidemiology and pathophysiology of hyperglycemia in hospitalized patients, summarizes the evidence for benefits and harms of using insulin to treat hyperglycemic patients hospitalized with cardiovascular disease, and offers some practical management considerations.

AB - Hyperglycemia in patients with and without known diabetes is a common finding in patients hospitalized with cardiovascular disease, and is associated with poor outcomes. Investigators have been examining the role of insulin to treat patients with acute myocardial infarction since the 1960's. Until the 1990's most studies evaluated fixed doses of glucose-insulin-potassium (GIK) infusions. The Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) trial, published in 1995, evaluated the role of adjustable-dose insulin infusion to lower blood glucose. Its promising results spurred further interest and a number of trials evaluating the use of insulin to lower blood glucose in hospitalized patients - many of which included patients with cardiovascular disease - have been conducted over the last two decades with conflicting results. This manuscript reviews the epidemiology and pathophysiology of hyperglycemia in hospitalized patients, summarizes the evidence for benefits and harms of using insulin to treat hyperglycemic patients hospitalized with cardiovascular disease, and offers some practical management considerations.

UR - http://www.scopus.com/inward/record.url?scp=84867527977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867527977&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2012.08.034

DO - 10.1016/j.amjcard.2012.08.034

M3 - Article

C2 - 23062564

AN - SCOPUS:84867527977

VL - 110

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - SUPPL. 9

ER -